The report Disparities in screening and diagnosis for triple negative breast cancer describes the impact that social determinants of health and differences in access to screening and diagnosis have on the survival of women with Triple Negative Breast Cancer.
And it highlights how health policies in the United States can support women’s access to timely screening and diagnosis.
From the Tigerlily Foundation and Gilead Sciences